APOBEC3B-mediated corruption of the tumor cell immunopeptidome induces heteroclitic neoepitopes for cancer immunotherapy
DNA mutations induced by dysregulated APOBEC3 expression are associated with tumour-progression and therapeutic resistance, but also with the generation of neoepitopes. Here, the authors show that APOBEC3 function can be exploited in a vaccine setting to generate heteroclitic neoepitopes, enhancing...
Main Authors: | Christopher B. Driscoll, Matthew R. Schuelke, Timothy Kottke, Jill M. Thompson, Phonphimon Wongthida, Jason M. Tonne, Amanda L. Huff, Amber Miller, Kevin G. Shim, Amy Molan, Cynthia Wetmore, Peter Selby, Adel Samson, Kevin Harrington, Hardev Pandha, Alan Melcher, Jose S. Pulido, Reuben Harris, Laura Evgin, Richard G. Vile |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2020-02-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-020-14568-7 |
Similar Items
-
APOBEC3 Mediates Resistance to Oncolytic Viral Therapy
by: Amanda L. Huff, et al.
Published: (2018-12-01) -
Diverse immunotherapies can effectively treat syngeneic brainstem tumors in the absence of overt toxicity
by: Matthew R. Schuelke, et al.
Published: (2019-03-01) -
Oncolytic virotherapy induced CSDE1 neo-antigenesis restricts VSV replication but can be targeted by immunotherapy
by: Timothy Kottke, et al.
Published: (2021-03-01) -
Oncolytic virus-derived type I interferon restricts CAR T cell therapy
by: Laura Evgin, et al.
Published: (2020-06-01) -
Immunogenicity of self tumor associated proteins is enhanced through protein truncation
by: Tim Kottke, et al.
Published: (2016-01-01)